Loading the section…

TRLV: financial statements from SEC — TradeAlmanac

TRLV

Trulieve Cannabis Corp. Subordinate Voting Shares: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Revenue	287M	288M	302M	298M	284M	303M
Cost of revenue	117M	118M	119M	115M	111M	122M
Gross profit	170M	170M	183M	183M	173M	182M
Selling, general and administrative	105M	99M	101M	119M	149M	103M
Operating expenses	134M	128M	130M	150M	173M	132M
Operating income	36M	42M	53M	33M	618,000	50M
Pre-tax income	25M	29M	39M	20M	−13M	37M
Income tax	22M	53M	55M	52M	47M	47M
Net income	2M	−27M	−14M	−33M	−60M	−12M
Earnings per share	0.02	−0.11	−0.07	−0.16	−0.32	−0.04
Earnings per share, diluted	0.02	−0.11	−0.07	−0.16	−0.32	−0.04
Weighted average shares	193M	191M	191M	191M	190M	190M
Weighted average shares, diluted	198M	191M	191M	191M	190M	190M

Balance sheet

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	353M	256M	449M	393M	328M	239M	238M	355M
Short-term investments	—	0

Cash flow

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Operating cash flow	56M	—	—	51M	—	—
Depreciation and amortisation	30M	29M	29M	29M

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator